People with MS who contracted Covid-19 did no worse than the general population according to preliminary results from Italy.
Researchers in Italy have been collecting data to understand the relationship between MS and Covid-19. They’re trying to understand whether having MS increases the risk of a more severe Covid-19 infection, and whether taking disease modifying drugs may add any extra risk.
The Italian Multiple Sclerosis Society (AISM), the Italian Multiple Sclerosis Foundation (FISM), and the Multiple Sclerosis Study Group of the Italian Neurological Society set up an online platform to record and collect data about people with MS in Italy who have been diagnosed with Covid-19 or have developed symptoms (suspected Covid-19). MS neurologists across Italy were asked to input data and share patient outcomes.
Early results from the data they’ve collected so far have now been published. Their preliminary data includes 232 people with MS who have tested positive for Covid-19 (57 people) or have suspected Covid-19 (175 people). Of the 232 people, 211 were taking a disease modifying drug.
The data recorded the severity of Covid-19 in these 232 people:
- 222 (96%) had a mild infection
- 4 (2%) had a severe infection
- 6 (3%) had a critical infection
Of those who were critical, one person recovered and five people died. The people who died tended to be older (50+) and have other health conditions.
It's too early to say from this data whether DMDs make a difference to Covid-19 recovery, but it does not suggest that the current DMD advice should be changed.
Although this research is preliminary and the numbers are fairly small, these results are reassuring for people with MS. They suggest that having MS doesn’t increase your likelihood of a more severe Covid-19 infection and that the majority of people with MS are likely to have a mild infection, the same as the general population.
Top tips for coping with the coronavirus lockdown
Helena and Marissa, two members of MS Trust team who live with MS, chat about how they are coping with self-isolation, and the things that are helping them get through this very strange time.
How to stay calm and carry on during the coronavirus crisis when you have MS
With the constant and ever-changing advice about what to do in the current COVID-19 outbreak, you might feel like you are struggling. You might worry about having to self-isolate or getting ill yourself. Here, Helena Jidborg Alexander, from the MS Trust's Information Team, takes a look at ways to look after your own mental wellbeing during these strange and scary times.
Coronavirus COVID-19 and multiple sclerosis
Up to date advice and guidance on coronavirus and Covid-19 for people affected by multiple sclerosis (MS).
Ofatumumab (Kesimpta) approved for relapsing MS in England and Wales
20 Apr 2021 - 00:00
The MS Trust is delighted that ofatumumab (Kesimpta) has been approved by NICE for people with active relapsing remitting multiple sclerosis.
Under-the-skin injection of Tysabri gets licence in UK and Ireland
16 Apr 2021 - 00:00
Under-the-skin (subcutaneous) injection of Tysabri (natalizumab) has been approved for UK and Ireland.
Ofatumumab (Kesimpta) gets UK licence for relapsing remitting MS
14 Apr 2021 - 00:00
The MHRA has granted marketing authorisation for ofatumumab (Kesimpta) for active relapsing remitting MS.